Zobrazeno 1 - 10 of 65 pro vyhledávání: '"J E, Oesterling"'
4
Natural History of Prostatism: Longitudinal Changes in Voiding Symptoms in Community Dwelling Men
Autor: S J, Jacobsen, C J, Girman, H A, Guess, T, Rhodes, J E, Oesterling, M M, Lieber
Publikováno v: Journal of Urology. 155:595-600
We report the results of 3 contacts during 42 months of The Olmsted County Study of Urinary Symptoms and Health Status Among Men, a longitudinal cohort study of men 40 to 79 years old that was initiated in 1990 to describe changes in lower urinary tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2598726826aba444441b4aa4cdb93d2
https://doi.org/10.1016/s0022-5347(01)66461-9
Zobrazit plný text záznamu
7
Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride. Finasteride PSA Study Group
Autor: J E, Oesterling, J, Roy, A, Agha, T, Shown, T, Krarup, T, Johansen, M, Lagerkvist, G, Gormley, M, Bach, J, Waldstreicher
Publikováno v: Urology. 51(4A)
The effects of finasteride on prostate-specific antigen (PSA) variability and usefulness in prostate cancer detection were examined.Percent change and crossover of PSA levels between the low (1.0 to 3.9 ng/mL) and high (4.0 to 10.0 ng/mL) ranges were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bc03b1aee5358625d3e04dddc4286fdf
https://pubmed.ncbi.nlm.nih.gov/9586598
Zobrazit plný text záznamu
8
Benign prostatic hyperplasia: use of drug therapy in primary care
Autor: R, Beduschi, M C, Beduschi, J E, Oesterling
Publikováno v: Geriatrics. 53(3)
Age and normal male androgenic function are the two most well-established risk factors for benign prostatic hyperplasia. Clinical manifestations of BPH may range from minimally bothersome symptoms to urinary retention and renal failure. Digital recta
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3bad48637487272377da011b04f54fd6
https://pubmed.ncbi.nlm.nih.gov/9511773
Zobrazit plný text záznamu
9
A model for the number of cores per prostate biopsy based on patient age and prostate gland volume
Autor: A R, Vashi, K J, Wojno, B, Gillespie, J E, Oesterling
Publikováno v: The Journal of urology. 159(3)
The systematic sextant biopsy is currently the gold standard for the tissue diagnosis of prostate cancer. However, it is unknown whether this 6 core approach provides optimal sampling of all prostate glands in men of all ages. The goal of the current
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d42b17ca2862421604d70c8b096ec823
https://pubmed.ncbi.nlm.nih.gov/9474183
Zobrazit plný text záznamu
10
Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin. HYCAT Investigator Group. Hytrin Community Assessment Trial
Autor: C G, Roehrborn, J E, Oesterling, P J, Olson, R J, Padley
Publikováno v: Urology. 50(4)
To prospectively analyze whether the treatment of men with clinically benign prostatic hyperplasia (BPH) with alpha blocking agents affects the serum prostate-specific antigen (PSA) levels, and to determine the magnitude of such effect.Serial PSA mea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::38ac3d2f04e58090a4be22026c91b873
https://pubmed.ncbi.nlm.nih.gov/9338731
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje